Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

Also called NCT01676285

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01676285
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01676285. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
Acronym
CARE Cirrhosis
Condition
Cirrhosis
Condition
Cirrhotic Cardiomyopathy
Condition
Cardiac Remodeling
Intervention (Drug)
Metoprolol succinate
Intervention (Drug)
placebo
Lead sponsor
University of Sao Paulo (class: other)
Collaborator
Fundação de Amparo à Pesquisa do Estado de São Paulo (class: other government)

Record details

Record id
cardio:ct-nct01676285
Content hash
d55a8a5225459f8b43797add6bf208cca2bb2a82b3bc40af878a843dbd033a12